References
- Amadio J, Gordon K, Murphy CD. (2010). Biotransformation of flurbiprofen by Cunninghamella species. Appl Environ Microbiol 76:6299–303
- Amadio J, Murphy CD. (2010). Biotransformation of fluorobiphenyl by Cunninghamella elegans. Appl Microbiol Biotechnol 86:345–51
- Amadio J, Murphy CD. (2011). Production of human metabolites of the anti-cancer drug flutamide via biotransformation in Cunninghamella species. Biotechnol Lett 33:321–6
- Asha S, Vidyavathi M. (2009). Cunninghamella-a microbial model for drug metabolism studies-a review. Biotechnol Adv 27:16–29
- Bright TV, Dalton F, Elder VL, et al. (2013). A convenient chemical-microbial method for developing fluorinated pharmaceuticals. Org Biomol Chem 11:1135–42
- Ghosal A, Xiaowen L, Penner N, et al. (2011). Identification of human liver cytochrome P450 enzymes involved in the metabolism of SCH 530348 (vorapaxar), a potent oral thrombin protease-activated receptor 1 antagonist. Drug Metab Dispos 39:30–8
- Jarvis L. (2015). The year in new drugs. Chem Engin News 93:11–16
- Kaul KL, Novak RF. (1987). Inhibition and induction of rabbit liver microsomal cytochrome P450 by pyridine. J Pharmacol Exp Ther 243:384–90
- Koerts J, Verlaeds MC, Soffers A, et al. (1997). Influence of substituents in fluorobenzene derivatives on the cytochrome P450-catalysed hydroxylation at the adjacent ortho aromatic carbon centre. Chem Res Toxicol 10:279–88
- Ma L, Liu X, Liang J, Zhang Z. (2011). Biotransformations of cinnamaldehyde, cinnamic acid and acetophenone with Mucor. World J Microbiol Biotechnol 27:2133–7
- Murphy CD. (2015). Drug metabolism in microorganisms. Biotechnol Lett 37:19–28
- Murphy CD, Sandford G. (2015). Recent advances in fluorination techniques and their anticipated impact on drug metabolism and toxicity. Expert Opin Drug Metab Toxicol 11:589–99
- Obach RS. (1999). Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and non-specific binding to microsomes. Drug Metab Dispos 27:1350–9
- Ong V, Flanagan S, Fang E, et al. (2014). Absorption, distribution, metabolism, and excretion of the novel antibacterial prodrug tedizolid phosphate. Drug Metab Dispos 42:1275–84
- Parshikov IA, Netrusov AI, Sutherland JB. (2012). Microbial transformation of azaarenes and potential uses in pharmaceutical synthesis. Appl Microbiol Biotechnol 95:871–89
- Rietjens I, Soffers A, Veeger C, Vervoort J. (1993). Regioselectivity of cytochrome P-450 catalyzed hydroxylation of fluorobenzenes predicted by calculated frontier orbital substrate characteristics. Biochemistry 32:4801–12
- Shaughnessy MJ, Harsanyi A, Li JJ, et al. (2014). Targeted fluorination of a nonsteroidal anti-inflammatory drug to prolong metabolic half-life. ChemMedChem 9:733–6
- Sutherland JB, Freeman JP, Heinze TM, et al. (2001). Oxidation of phenothiazine and phenoxazine by Cunninghamella elegans. Xenobiotica 31:799–809
- Sutherland JB, Freeman JP, Williams AJ, Cerniglia CE. (1994). N-oxidation of quinoline and isoquinoline by Cunninghamella elegans. Exp Mycol 18:271–4
- Sutherland JB, Freeman JP, Williams AJ, Deck J. (1998). Metabolism of cinnoline to N-oxidation products by Cunninghamella elegans and Aspergillus niger. J Indust Microbiol Biotechnol 21:225–7
- Winkler M, Winkler CK. (2016). Trametes versicolor carboxylate reductase uncovered. Monatshefte Fur Chemie 147:575–8
- Zeng J, Gage D, Zhan J. (2012). Production of a new pyridine N-oxide by bioconversion with Cunninghamella echinulata var. elegans. J Biosci Bioengin 114:497–9
- Zhang DL, Yang YF, Leakey JEA, Cerniglia CE. (1996). Phase I and phase II enzymes produced by Cunninghamella elegans for the metabolism of xenobiotics. FEMS Microbiol Lett 138:221–6